Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: The influence of local oxygenation changes

Journal of Radiation Research

Volumn 55, Issue 5, 2014, Pages 902-911

  Antonovic, Laura ^a   Lindblom, Emely ^a   Dasu, Alexandru ^b   Bassler, Niels ^c   Furusawa, Yoshiya ^d,e   Toma Dasu, Iuliana ^a,f  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c AARHUS UNIVERSITY   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

carbon ion; fractionation; hypoxia; LOC; OER; RCR; TCP

Indexed keywords

CARBON; ENERGY TRANSFER; IONS; OXYGEN; OXYGENATION; PROBABILITY; RADIOTHERAPY; TRANSMISSION CONTROL PROTOCOL;

CARBON ION RADIOTHERAPY; CARBON IONS; ENHANCEMENT RATIOS; HYPOXIA; LOCAL OXYGENATION CHANGE; LOCAL OXYGENATIONS; OXYGEN ENHANCEMENT; OXYGEN ENHANCEMENT RATIO; REPAIRABLE-CONDITIONALLY REPAIRABLE; TUMOR CONTROL PROBABILITY;

TUMORS;

CARBON; HEAVY ION; OXYGEN;

BIOLOGICAL MODEL; CELL HYPOXIA; CELL SURVIVAL; COMPUTER SIMULATION; ION THERAPY; LINEAR ENERGY TRANSFER; METABOLISM; NEOPLASMS; OXYGEN CONSUMPTION; PATHOLOGY; PROCEDURES; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; STATISTICAL MODEL; TREATMENT OUTCOME;

CARBON; CELL HYPOXIA; CELL SURVIVAL; COMPUTER SIMULATION; DOSE FRACTIONATION; HEAVY ION RADIOTHERAPY; HEAVY IONS; LINEAR ENERGY TRANSFER; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; TREATMENT OUTCOME;

EID: 84904051666     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rru020     Document Type: Article

References (40)

1. Hall E, Giaccia A. Radiobiology for the Radiologist, 6th edn. Philadelphia: LippincottWilliams &Wilkins, 2006.
2. Furusawa Y, Fukutsu K, Aoki M et al. Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated 3He-, 12C-and 20Ne-ion beams. Radiat Res 2000;154:485-9.
3. Horsman MR, Ov ergaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 2007;19:418-26.
4. Toma-Dasu I, Uhrdin J, Antonovic L et al. Dose prescription and treatment planning based on FMISO-PET hypoxia. Acta Oncol 2012;51:222-30.
5. Bassler N, Jä kel O, Søndergaard CS et al. Dose-and LET-painting with particle therapy. Acta Oncol 2010;49: 1170-76.
6. Bassler N, Toftegaard J, L ühr A et al. LET-painting increases tumour control probability in hypoxic tumours. Acta Oncol 2014;53:25-32.
7. Scifoni E, Tinganelli W, Weyrather W K et al. Including oxygen enhancement ratio in ion beam treatment planning: model implementation and experimental verification. Phys Med Biol 2013;58:3871-95.
8. Wang J, Li R, Gu o C et al. The influence of fractionation on cell survival and premature differentiation after carbon ion irradiation. J Radiat Res 2008;49:391-8.
9. Ljungkvist A, Bussink J, Kaanders J et al. Hypoxic cell turnover in different solid tumor lines. Int J Radiat Oncol Biol Phys 2005;62:1157-68.
10. Ljungkvist A, Bussink J, Kaanders J et al. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiat Res 2006;165:326-36.
11. Redler G, Epel B, Halpern H. Principal component analysis enhances SNR for dynamic electron paramagnetic resonance o xygen imaging of cycling hypoxia in vivo. Magn Reson Med 2014;71:440-50.
12. Lindblom E. The impact of hypoxia on tumour control probability in the high-dose range used in stereotactic body radiation therapy. Master's Thesis, Stockholm University, 2012.
13. Miyamoto T, Baba M, Yamamoto N et al. Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen . Int J Radiat Oncol Biol Phys 2007;67:750-58.
14. Miyamoto T, Baba M, Sugane T et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2007;2:916-26.
15. Okada T, Tsuji H, Kamada T et al. Carbon ion radiotherapy in advanced hypofractionated regimens for pros tate cancer: from 20 to 16 fractions. Int J Radiat Oncol Biol Phys 2012;84: 968-72.
16. Habermehl D,Debus J,Ganten T,et al. Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma-feasibility and clinical response. Radiat Oncol 2013, 8, 59-66.
17. Dasu A, Toma-Dasu I, Karlsson M. Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia Phys Med Biol 2003;48:2829-42.
18. Konerding MA, Malkusch W, Klapthor B. Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br J Cancer 1999;80:724-32.
19. Dasu A, Toma-Dasu I, Karlsson M. The effects of hypoxia on the theoretical modelling of tumour control probability. Acta Oncol 2005;44:563-71.
20. Toma-Dasu I, Dasu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol 2009;48:1181-92.
21. Krä mer M, Scholz M. Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. Phys Med Biol 2000;45:3319-30.
22. Lind BK, Persson LM, Edgren MR et al. Repairable-conditionally repairable damage model based on dual Poisson processes. Radiat Res 2003;160:366-75.
23. Wedenberg M, Lind BK, Toma-Daşu I et al. Analytical description of the LET dependence of cell survival usin g the repairable-conditionally repairable damage model. Radiat Res 2010;174:517-25.
24. Antonovic L, Brahme A, Furusawa Y et al. Radiobiological description of the LET dependence of the cell sur vival of oxic and anoxic cells irradiated by carbon ions. J Radiat Res 2013;54:18-26.
25. Alper T, Howard-Flanders P. Role of oxygen in modifying the radiosensitivity of E. coli B. Nature 1956;178:978-9.
26. Alper T. Cellular Radiobiology. Cambridge: Cambridge University Press, 1979.
27. Kanai T, Matsufuji N, Miyamoto T et al. Examination of GyE system for HIMAC carbon therapy. Int J Radiat Oncol Biol Phys 2006;64:650-6.
28. Tsujii H, Mizoe J, Kamada T et al. Clinical results of carbon ion RT at NIRS. J Radiat Res 2007;48 Suppl.:A1-13.
29. Dasu A, Toma-Dasu I. Prostate alpha/beta revisited-an analysis of clinical results from 14 168 patients. Acta Oncol 2012;51:963-74.
30. Dasu A, Toma-Dasu I, Fowler JK. Should single or distributed parameters be used to explain the steepness of tumour control probability curves? Phys Med Biol 2003;48:387-97.
31. Elkind M, Whitmore G. Radiobiology of Cultured Mammalian Cells. New York: Gordon and Breach, 1967.
32. Ellis F. Dose time and fractionation in radiotherapy. In: Elbert M, Howard A (eds). Current Topics in Radiation Research, Vol. 4. Amsterdam: North-Holland Publishing Co., 1968, 359-97.
33. Brahme A. Accurate des cription of the cell survival and biological effect at low and high doses and LET's. J Radiat Res 2011;52:389-407.
34. Suit H, DeLaney T, Goldberg S et al. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients, Radiother Oncol 2010;95:3-22.
35. Nakano T, Suzuki Y, Ohno T et al. Carbon beam therapy overcomes the radiation resistance of uterine cervical canc er originating from hypoxia. Clin Cancer Res 2006;12:2185-90.
36. Fowler JF, Tomé W, Fenwick J et al. A challenge to traditional radiation oncology, Int J Radiat Oncol Biol Phys 2004;60:1241-56.
37. Denekamp J,Dasu A. Inducible repair and the two forms of tumour hypoxia-time for a paradigm shift. Acta Oncol 1999;38:903-18.
38. Ling CC, Robinson E, Shrieve DC. Repair of radiation induced damage-dependence on oxygen and energy status. Int J Radiat Oncol Biol Phys 1988;15:1179-86.
39. Pettersen EO, Wang H. Radiation-modifying effect of oxygen in synchronized cells pre-treated with acute or prolonged hypoxia. Int J Radiat Biol 1996;70:319-26.
40. Ma NY, Tinganelli W, Maier A et al. Influence of chronic hypoxia and radiation quality on cell survival. J Radiat Res 2013;54(Suppl 1):i13-22.